Overview
Taishi Kayano practices in Kyoto, Japan. Mr. Kayano is rated as an Advanced expert by MediFind in the treatment of COVID-19. His top areas of expertise are Rubella, Togaviridae Disease, COVID-19, and ADULT Syndrome.
His clinical research consists of co-authoring 27 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 15 articles in the study of COVID-19.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- ADULT SyndromeMr. Kayano isAdvanced. Learn about ADULT Syndrome.
- COVID-19Mr. Kayano isAdvanced. Learn about COVID-19.
- RubellaMr. Kayano isAdvanced. Learn about Rubella.
- Togaviridae DiseaseMr. Kayano isAdvanced. Learn about Togaviridae Disease.
- Experienced
- Avian InfluenzaMr. Kayano isExperienced. Learn about Avian Influenza.
- FluMr. Kayano isExperienced. Learn about Flu.
- Severe Acute Respiratory Syndrome (SARS)